Nature Reviews Genetics 8, 749-761 (October 2007) | doi:10.1038/nrg2164

Splicing in disease: disruption of the splicing code and the decoding machinery

Guey-Shin Wang1 & Thomas A. Cooper1,2  About the authors


Human genes contain a dense array of diverse cis-acting elements that make up a code required for the expression of correctly spliced mRNAs. Alternative splicing generates a highly dynamic human proteome through networks of coordinated splicing events. Cis- and trans-acting mutations that disrupt the splicing code or the machinery required for splicing and its regulation have roles in various diseases, and recent studies have provided new insights into the mechanisms by which these effects occur. An unexpectedly large fraction of exonic mutations exhibit a primary pathogenic effect on splicing. Furthermore, normal genetic variation significantly contributes to disease severity and susceptibility by affecting splicing efficiency.

Author affiliations

  1. Departments of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.
  2. Department of Molecular and Cellular Biology, Baylor College of Medicine.

Correspondence to: Thomas A. Cooper1,2 Email:

Published online 29 August 2007


These links to content published by NPG are automatically generated.


When chromatin meets splicing

Nature Structural & Molecular Biology News and Views (01 Sep 2009)

Mobile RNA catalysts

Nature News and Views (29 Dec 1988)

See all 3 matches for News And Views


Surrogate Endpoints for the Treatment of Venous Leg Ulcers

Journal of Investigative Dermatology Original Article

See all 36 matches for Research